Category:FDA approved in 2022

From HemOnc.org - A Hematology Oncology Wiki

Jump to navigation Jump to search

Pages in category "FDA approved in 2022"

The following 6 pages are in this category, out of 6 total.

C

Ciltacabtagene autoleucel (Carvykti)

G

Gallium Ga 68 gozetotide (Locametz)

L

Lutetium Lu 177 vipivotide tetraxetan (Pluvicto)

N

Nivolumab and relatlimab (Opdualag)

P

Pacritinib (Vonjo)

T

Tebentafusp (Kimmtrak)

Retrieved from "https://hemonc.org/w/index.php?title=Category:FDA_approved_in_2022&oldid=54265"

FDA approved in the 2020s